Research Keyword: drug-resistant pathogens

Ploidy plasticity drives fungal resistance to azoles used in agriculture and clinics

mycolabadmin

Agricultural fungicides called azoles can cause fungi to change their genetic makeup in ways that make them resistant to medical antifungal drugs. Researchers found that when Candida tropicalis (a fungal pathogen) is exposed to tebuconazole, an agricultural fungicide, it can transform into a haploid form (with half the normal chromosomes) that is resistant to both agricultural and clinical azoles. This discovery helps explain why fungal infections are becoming harder to treat in hospitals.

Read More »

Microbe Profile: Streptomyces formicae KY5: an ANT-ibiotic factory

mycolabadmin

Scientists have discovered a special bacterium called Streptomyces formicae that lives in ant nests and produces powerful antibiotics. This bacterium makes formicamycins, which can kill dangerous bacteria like methicillin-resistant Staphylococcus aureus that resists many common antibiotics. Using advanced genetic tools, researchers can modify this bacterium to unlock hidden antibiotic-producing pathways, potentially leading to new medicines to fight drug-resistant infections.

Read More »

Microbe Profile: Streptomyces formicae KY5: an ANT-ibiotic factory

mycolabadmin

Scientists discovered a special bacterium called Streptomyces formicae living with plant-ants in Africa that produces powerful antibiotics. This bacterium can kill dangerous drug-resistant bacteria and fungi that are hard to treat with current medicines. By using genetic tools, researchers are unlocking the bacterium’s hidden potential to create many more new antibiotics that could help fight infections.

Read More »

Drug repurposing to fight resistant fungal species: Recent developments as novel therapeutic strategies

mycolabadmin

This editorial highlights the growing problem of fungal infections that resist current treatments, causing millions of deaths worldwide each year. Researchers are finding new ways to fight these resistant infections by repurposing existing drugs in new combinations and discovering novel compounds from natural sources. The collection of studies presented shows promising results using combinations like minocycline with antifungal drugs, natural compounds like baicalin, and AI technology to predict resistance patterns. These innovative approaches offer hope for better treatment options for patients suffering from serious fungal infections.

Read More »

Microbe Profile: Streptomyces formicae KY5: an ANT-ibiotic factory

mycolabadmin

Scientists discovered a special bacterium called Streptomyces formicae living in ant nests in Africa that produces powerful antibiotics effective against dangerous drug-resistant bacteria and fungi. This bacterium has the genetic potential to make at least 45 different antimicrobial compounds, though most are not currently being produced under standard laboratory conditions. Using advanced gene-editing techniques like CRISPR, researchers are working to activate these hidden pathways to discover new medicines. This research demonstrates how exploring bacteria in nature can lead to finding new antibiotics to treat serious infections.

Read More »
Scroll to Top